PTGS2 and neoplasm: Broad inhibition of prostanoid synthesis by targeting the upstream synthase COX2 has been shown to reduce tumor growth and metastasis, reverse collagen deposition, sensitize tumors to immunotherapy, normalize the vasculature, and enhance the response to chemotherapy in mouse models.7